Showing results (971-980 of 5,527) with videos related to

Sort By:
Pageof 553
Annals of Medicine|December 10, 2025
A comparison of allied healthcare versus no allied healthcare on participation, fatigue, physical functioning and health-related quality of life for patients with persistent complaints after a COVID-19 infectionÂngela Jornada Ben, Anita Natalia Varga, Siméon de Bruijn, et al.
Annals of Medicine|November 28, 2025
Trends and burden of inflammatory bowel disease in children (aged 0-14 years) in Asia and Europe, 1990-2021: a global burden of disease 2021 analysisWeiwei Cao, Ye Han, Xingtao Jin, et al.
Annals of Medicine|December 1, 2025
An ethical issue in the prenatal and postnatal management of trisomy 18: a survey of obstetriciansAyşe Figen Türkçapar, Nüket Örnek Büken
Annals of Medicine|June 18, 2025
Effect of regional nerve block on tourniquet-related injury in pediatric patients undergoing lower limb surgery: a randomized controlled studyQin Xia, Rui Chen, Chao Lin, et al.
Annals of Medicine|February 13, 2025
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver diseaseXiangyong Hao, Hao Song, Xin Su, et al.
Annals of Medicine|February 13, 2025
Adverse childhood experiences and intimate partner violence in adulthood among transgender women: exploring the chain mediating role of self-esteem and LGBT minority stressLulu Xu, Huifang Xu, Zuxin Wang, et al.
Annals of Medicine|February 14, 2025
Efficacy and safety of tetracycline vs. amoxicillin in furazolidone-based rescue therapy for Helicobacter pylori: a real-world analysisJinliang Xie, Jianxiang Peng, Shuang Wu, et al.
Annals of Medicine|December 19, 2024
Serum free light chain level-based and non-fixed cycle daratumumab treatment strategy for patients with light chain amyloidosisZhen Li, Jinzhou Guo, Wencui Chen, et al.
Annals of Medicine|December 19, 2024
Temporal trends in gender, etiology, severity and outcomes of acute pancreatitis in a third-tier Chinese city from 2013 to 2021Yining Huang, Minhao Qiu, Shuang Pan, et al.
Annals of Medicine|December 23, 2024
The efficacy and safety of anlotinib plus PD-1 inhibitor in locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) patients who progressed on prior immune checkpoint inhibitors (ICIs): a retrospective real-world study (NCT 04984096)Xueru Zhu, Xiumei Ma, Hongxuan Li, et al.
Pageof 553